224 related articles for article (PubMed ID: 15544628)
1. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype.
Creery WD; Diaz-Mitoma F; Filion L; Kumar A
Eur J Immunol; 1996 Jun; 26(6):1273-7. PubMed ID: 8647204
[TBL] [Abstract][Full Text] [Related]
4. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
Subauste CS; de Waal Malefyt R; Fuh F
J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
[TBL] [Abstract][Full Text] [Related]
5. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-simulating irradiation.
Laihia JK; Jansen CT
Eur J Immunol; 1997 Apr; 27(4):984-9. PubMed ID: 9130654
[TBL] [Abstract][Full Text] [Related]
8. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells.
Yokozeki H; Katayama I; Ohki O; Arimura M; Takayama K; Matsunaga T; Satoh T; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):831-7. PubMed ID: 9217813
[TBL] [Abstract][Full Text] [Related]
10. Rapid cytokine up-regulation of integrins, complement receptor 1 and HLA-DR on monocytes but not on lymphocytes.
Limb GA; Hamblin AS; Wolstencroft RA; Dumonde DC
Immunology; 1992 Sep; 77(1):88-94. PubMed ID: 1356917
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.
Willems F; Marchant A; Delville JP; Gérard C; Delvaux A; Velu T; de Boer M; Goldman M
Eur J Immunol; 1994 Apr; 24(4):1007-9. PubMed ID: 7512027
[TBL] [Abstract][Full Text] [Related]
12. Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.
Nissen MH; Larsen JK; Plesner T; Olesen BK; Ernst P
Clin Exp Immunol; 1987 Sep; 69(3):632-8. PubMed ID: 2959413
[TBL] [Abstract][Full Text] [Related]
13. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
[TBL] [Abstract][Full Text] [Related]
14. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon.
Tsukada N; Aoki S; Maruyama S; Kishi K; Takahashi M; Aizawa Y
J Exp Clin Cancer Res; 1997 Jun; 16(2):171-6. PubMed ID: 9261743
[TBL] [Abstract][Full Text] [Related]
15. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
Genç K; Dona DL; Reder AT
J Clin Invest; 1997 Jun; 99(11):2664-71. PubMed ID: 9169496
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes.
Kiener PA; Moran-Davis P; Rankin BM; Wahl AF; Aruffo A; Hollenbaugh D
J Immunol; 1995 Nov; 155(10):4917-25. PubMed ID: 7594496
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of human, antigen-specific Th1 and Th2 responses by the B-7 homologues, CD80 and CD86.
Bashian GG; Braun CM; Huang SK; Kagey-Sobotka A; Lichtenstein LM; Essayan DM
Am J Respir Cell Mol Biol; 1997 Aug; 17(2):235-42. PubMed ID: 9271312
[TBL] [Abstract][Full Text] [Related]
19. Identification of a dynamic intracellular reservoir of CD86 protein in peripheral blood monocytes that is not associated with the Golgi complex.
Smyth C; Logan G; Weinberger RP; Rowe PB; Alexander IE; Smythe JA
J Immunol; 1998 Jun; 160(11):5390-6. PubMed ID: 9605139
[TBL] [Abstract][Full Text] [Related]
20. IgD expression on B cells is more efficient than IgM but both receptors are functionally equivalent in up-regulation CD80/CD86 co-stimulatory molecules.
Brink R; Goodnow CC; Basten A
Eur J Immunol; 1995 Jul; 25(7):1980-4. PubMed ID: 7542598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
